Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.

被引：0
|
作者：
Lheureux, Stephanie [1 ]
Yang, Cindy [2 ]
Shaw, Patricia [1 ]
Clarke, Blaise [1 ]
Tsao, Julissa [2 ]
Karakasis, Katherine [1 ]
Butler, Marcus [1 ]
Salman, Noor [2 ]
Dowar, Mark [2 ]
Xu, Jing [1 ]
Poulain, Laurent [3 ]
Ohashi, Pamela S. [1 ]
Pugh, Trevor [2 ]
Oza, Amit [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto, ON, Canada
[3] Ctr Francois Baclesse, F-14021 Caen, France
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.OVCA15-A35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A35
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical features of long-term survivors with advanced high-grade serous ovarian cancer.
    Barretina-Ginesta, Maria-Pilar
    Bague, Anna Carbo
    Bujons, Elisabet
    Fortian, Arola
    Fina, Claudia
    Pardo, Marta
    Melendez-Munoz, Cristina
    Cardenas, Laura
    Taltavull, Anna
    Sabate, Josep
    Darder, Esther
    Feliubadalo, Lidia
    Barretina, Jordi
    Brunet, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Prediction of Platinum-based Chemotherapy Response in Advanced High-grade Serous Ovarian Cancer: ADC Histogram Analysis of Primary Tumors
    Lu, Jing
    Li, Hai Ming
    Cai, Song Qi
    Zhao, Shu Hui
    Ma, Feng Hua
    Li, Yong Ai
    Ma, Xiao Liang
    Qiang, Jin Wei
    [J]. ACADEMIC RADIOLOGY, 2021, 28 (03) : e77 - e85
  • [3] The genomic landscape of high-grade serous ovarian cancer in long-term survivors
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje C.
    Saner, Flurina
    Beach, Jessica A.
    Milne, Katy
    Kennedy, Catherine J.
    Hendley, Joy
    Traficante, Nadia
    Pearce, Celeste L.
    Pike, Malcolm C.
    Ramus, Susan J.
    Kobel, Martin
    Nelson, Brad H.
    Goode, Ellen L.
    deFazio, Anna
    Bowtell, David D.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Feng, Zheng
    Shao, Di
    Cai, Yuhang
    Bi, Rui
    Ju, Xingzhu
    Chen, Dongju
    Song, Chengcheng
    Chen, Xiaojun
    Li, Jin
    An, Na
    Li, Yunjin
    Zhou, Qing
    Xiu, Zhihui
    Zhu, Shida
    Wu, Xiaohua
    Wen, Hao
    [J]. JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [5] Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
    Zheng Feng
    Di Shao
    Yuhang Cai
    Rui Bi
    Xingzhu Ju
    Dongju Chen
    Chengcheng Song
    Xiaojun Chen
    Jin Li
    Na An
    Yunjin Li
    Qing Zhou
    Zhihui Xiu
    Shida Zhu
    Xiaohua Wu
    Hao Wen
    [J]. Journal of Ovarian Research, 16
  • [6] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
  • [7] Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
    Andrikopoulou, Angeliki
    Theofanakis, Charalampos
    Markellos, Christos
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Apostolidou, Kleoniki
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    Liontos, Michalis
    [J]. CANCERS, 2023, 15 (13)
  • [8] Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
    Tomao, Federica
    Musacchio, Lucia
    Di Mauro, Federica
    Boccia, Serena Maria
    Di Donato, Violante
    Giancotti, Antonella
    Perniola, Giorgia
    Palaia, Innocenza
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 (01) : 138 - 143
  • [9] Survival of patients with stage IV high-grade serous ovarian cancer treated with intraperitoneal versus intravenous platinum-based chemotherapy
    Alharbi, Hamad
    Kim, Soyoun Rachel
    Maganti, Manjula
    May, Taymaa
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S247 - S247
  • [10] Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
    Larionova, Irina
    Iamshchikov, Pavel
    Kazakova, Anna
    Rakina, Militsa
    Menyalo, Maxim
    Enikeeva, Kadriia
    Rafikova, Guzel
    Sharifyanova, Yuliya
    Pavlov, Valentin
    Villert, Alisa
    Kolomiets, Larisa
    Kzhyshkowska, Julia
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
12345